Martingale Asset Management L P reduced its position in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 0.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 38,603 shares of the medical instruments supplier’s stock after selling 1 shares during the period. Martingale Asset Management L P’s holdings in ICU Medical, were worth $5,895,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in ICUI. Creative Planning increased its position in shares of ICU Medical, by 315.6% in the first quarter. Creative Planning now owns 665 shares of the medical instruments supplier’s stock worth $102,000 after buying an additional 505 shares in the last quarter. Sawgrass Asset Management LLC acquired a new stake in ICU Medical, during the first quarter worth $229,000. Cypress Wealth Advisors LLC acquired a new stake in ICU Medical, during the fourth quarter worth $238,000. Janney Montgomery Scott LLC boosted its stake in ICU Medical, by 0.4% in the first quarter. Janney Montgomery Scott LLC now owns 1,607 shares of the medical instruments supplier’s stock worth $245,000 after buying an additional 7 shares during the last quarter. Finally, State of Alaska Department of Revenue boosted its stake in ICU Medical, by 2.5% in the first quarter. State of Alaska Department of Revenue now owns 1,640 shares of the medical instruments supplier’s stock worth $250,000 after buying an additional 40 shares during the last quarter. Institutional investors and hedge funds own 88.72% of the company’s stock.
Shares of ICU Medical, Incorporated (NASDAQ:ICUI) traded up 1.18% during mid-day trading on Friday, reaching $163.15. The company’s stock had a trading volume of 135,908 shares. The company’s 50-day moving average is $154.23 and its 200-day moving average is $148.00. ICU Medical, Incorporated has a 52 week low of $100.27 and a 52 week high of $175.73. The stock has a market capitalization of $3.23 billion, a price-to-earnings ratio of 29.00 and a beta of 0.33.
ICU Medical, (NASDAQ:ICUI) last issued its quarterly earnings data on Wednesday, May 10th. The medical instruments supplier reported $1.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $1.23. The company had revenue of $247.74 million for the quarter, compared to analyst estimates of $237.12 million. ICU Medical, had a return on equity of 10.70% and a net margin of 15.18%. The business’s quarterly revenue was up 175.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.26 earnings per share. Equities analysts predict that ICU Medical, Incorporated will post $4.14 EPS for the current year.
TRADEMARK VIOLATION WARNING: This report was originally reported by Mideast Time and is owned by of Mideast Time. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.mideasttime.com/martingale-asset-management-l-p-sells-1-shares-of-icu-medical-incorporated-icui/1708482.html.
ICUI has been the subject of a number of recent analyst reports. Zacks Investment Research raised ICU Medical, from a “strong sell” rating to a “buy” rating and set a $166.00 price objective for the company in a research report on Wednesday, March 8th. Roth Capital cut ICU Medical, from a “buy” rating to a “neutral” rating in a research report on Thursday, May 11th. They noted that the move was a valuation call.
In other news, VP Alison D. Burcar sold 18,290 shares of the stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $160.72, for a total transaction of $2,939,568.80. Following the completion of the sale, the vice president now owns 3,727 shares in the company, valued at $599,003.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Vivek Jain sold 589 shares of the stock in a transaction dated Monday, March 6th. The stock was sold at an average price of $150.00, for a total transaction of $88,350.00. Following the sale, the chairman now owns 64,089 shares of the company’s stock, valued at approximately $9,613,350. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 84,428 shares of company stock worth $12,994,882. Corporate insiders own 15.90% of the company’s stock.
ICU Medical, Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.